Search results for "pic"

showing 10 items of 8215 documents

Evaluation of efficacy and biocompatibility of a new absorbable synthetic substitute as a dural onlay graft in a large animal model.

2016

Numerous dura substitutes are commercially available, but no absorbable synthetic dura repair product has been used for both onlay and suture applications.The safety and effectiveness of a new absorbable synthetic substitute composed of Poly-L-lactide microfibers as onlay dural graft were evaluated.Physical properties and performance of the microfibrous synthetic dural substitute implanted as an onlay or suturable grafts were compared with these commercial products, including CODMAN ETHISORB™ Dura Patch and DuraGen™ Dural Graft Matrix, in a canine duraplasty model. The cerebrospinal fluid (CSF) leakage, macroscopic and microscopic observation at 30 and 90 days after implantation were invest…

musculoskeletal diseasesmedicine.medical_specialtyTime FactorsBiocompatibilityPolyesters02 engineering and technologyDural graftIn Vitro Techniques03 medical and health sciences0302 clinical medicineDogsDural substitutemedicineAnimalsCsf leakageCerebrospinal Fluid Leakbusiness.industryGeneral Medicine021001 nanoscience & nanotechnologynervous system diseasesSurgeryMicroscopic observationDisease Models AnimalNeurologyInlaysNeurology (clinical)Dura Mater0210 nano-technologybusiness030217 neurology & neurosurgeryLarge animalNeurological research
researchProduct

Is time to joint replacement a valid outcome measure in clinical trials of drugs for osteoarthritis?

2003

The rate of radiographic joint space narrowing is commonly used today as a structural outcome measure in clinical trials evaluating potential disease-modifying drugs in patients with hip osteoarthritis, but this results in a continuous variable. Among the methods proposed to circumvent this problem, it has been suggested that the incidence of total hip arthoplasty (THA) provides a hard outcome measure. It is a dichotomized variable, easy to measure and sensitive to change, with acceptable intrinsic validity. However, because this measure is limited by the variability of factors underlying the decision to perform surgery and the length of waiting lists, it has been suggested that time to ful…

musculoskeletal diseasesmedicine.medical_specialtyTime FactorsJoint replacementEndpoint Determinationmedicine.medical_treatmentArthroplasty Replacement HipInternational CooperationMeasure (physics)OsteoarthritisContinuous variableRheumatologyReference ValuesArthropathyOsteoarthritismedicineHumansClinical Trials as Topicbusiness.industryIncidence (epidemiology)Outcome measuresmedicine.diseaseClinical trialTreatment OutcomePhysical therapybusinessRheumatic diseases clinics of North America
researchProduct

MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

2008

Abstract Background Infliximab is a widely used biological agent for the treatment of inflammatory bowel disease, and has a favorable risk/benefit ratio. Aim It is useful to know that patients treated with infliximab are exposed to developing adverse events that could be reduced with a prudent and a rational clinical approach and by optimizing the treatment protocol. Methods PubMed (including Epub) was searched in October 2006 and again in March 2007. Results The high immunogenic potential of infliximab determines the antibodies that inhibit the effect of infliximab and the appearance of subsequent acute and delayed infusion reactions. Infliximab has an immunomodulatory effect, thus increas…

musculoskeletal diseasesmedicine.medical_specialtyTuberculosisInflammatory bowel diseaseGastroenterologyDrug Administration SchedulePharmacotherapyimmune system diseasesInternal medicinemedicineHumansImmunologic Factorsskin and connective tissue diseasesAdverse effectClinical Trials as TopicHepatologybusiness.industryTumor Necrosis Factor-alphaGastroenterologyAntibodies Monoclonalmedicine.diseaseInflammatory Bowel DiseasesInfliximabInfliximabLymphomastomatognathic diseasesHeart failureToxicityDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drug
researchProduct

Distal Humerus Fractures

2014

Distal humerus fractures display seldom but severe injuries because of the complex distal humerus anatomy and often comminuted fracture types. They account for approximately 2–3 % of all fractures and for 17–30 % of fractures around the elbow. In younger patients, there is a predominance among males. The mechanism of accident is mostly a high-energy trauma in this population. In contrast, among elderly patients, distal humerus fractures concern mostly women with osteoporotic bone. Fractures are caused by a low-energy trauma such as a fall from standing height onto the outstretched or slightly flexed arm. These fractures are often severely comminuted. Because of the thin soft tissue envelope…

musculoskeletal diseasesmedicine.medical_specialtyeducation.field_of_studybusiness.industryElbowPopulationDistal humerusSoft tissueAnatomymusculoskeletal systemmedicine.diseaseSurgerymedicine.anatomical_structuremedicine.arterymedicineOsteoporotic boneHeterotopic ossificationBrachial arteryeducationbusinessFracture type
researchProduct

Fourth case of louse-borne relapsing fever in Young Migrant, Sicily, Italy, December 2015. Mini Review Article

2016

Abstract Objectives Currently louse-borne relapsing fever (LBRF) is primarily found in limited endemic foci in Ethiopia, Somalia and Sudan; no case of imported LBRF has been reported in Europe in the 9 years prior to 2015. The aim of our paper is to describe a new case of imported LBRF detected in Sicily, Italy, and to review all cases reported in migrants arrived in Europe in the last 10 years. Study design Mini review of all published cases of louse-borne relapsing fever in Europe in the last 10 years. Methods A computerized search without language restriction was conducted using PubMed combining the terms ‘(louse-borne relapsing fever or LBRF or recurrentis) and (refugee or Europe or mig…

myalgiaAdultMalemedicine.medical_specialtyPediatricsRefugeerelapsing feverSomalia030231 tropical medicineDiagnosis Differential03 medical and health sciences0302 clinical medicineEpidemiologyBorrelia recurrentis; Europe; Louse-borne relapsing fever; Refugees; Public Health Environmental and Occupational HealthmedicineHumans030212 general & internal medicineLouse-Borne Relapsing FeverSicilyTransients and MigrantsLouse-borne relapsing feverbiologyBorrelia recurrentibusiness.industryPublic healthBorreliaRelapsing FeverPublic Health Environmental and Occupational HealthGeneral MedicineLice Infestationsmedicine.diseasebiology.organism_classificationEuropeFamily medicineChillsmedicine.symptomHeadachesbusinessBorrelia recurrentis
researchProduct

Mediterranean spotted fever: clinical and laboratory characteristics of 415 Sicilian children

2006

Abstract Background Mediterranean spotted fever (MSF) is an acute febrile, zoonotic disease caused by Rickettsia conorii and transmitted to humans by the brown dogtick Rhipicephalus sanguineus. Nearly four hundred cases are reported every year (mainly from June to September) on the Italian island of Sicily. The aim of the study was to analyze the clinical and laboratory characteristics of patients with MSF and the efficacy of the drugs administered. Methods Our study was carried out on 415 children with MSF, during the period January 1997 – December 2004, at the "G. Di Cristina" Children's hospital in Palermo, Sicily, Italy. On admission patients' clinical history, physical and laboratory e…

myalgiamedicine.medical_specialtyAdolescentRhipicephalus sanguineusBoutonneuse FeverAzithromycinlcsh:Infectious and parasitic diseasesInternal medicineClarithromycinmedicineHumanslcsh:RC109-216Childbiologybusiness.industryInfantmedicine.diseasebiology.organism_classificationRashAnti-Bacterial AgentsSpotted fevermediterranean spotted feverBoutonneuse feverInfectious DiseasesChild PreschoolImmunologymedicine.symptombusinessRickettsia conoriiResearch Articlemedicine.drugBMC Infectious Diseases
researchProduct

Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 pa…

2014

article i nfo Introduction: VitaminD (vitD)deficiencymay beassociatedwith anincreased riskof statin-related symptomatic myalgia in statin-treated patients. The aim of this meta-analysis was to substantiate the role of serum vitamin D levels in statin-associated myalgia. Methods: The search included PUBMED, Cochrane Library, Scopus, and EMBASE from January 1, 1987 to April 1, 2014 to identify studies that investigated the impact of vit D levels in statin-treated subjects with and without myalgia. Two independent reviewers extracted data on study characteristics, methods and outcomes. Quantita- tive data synthesis was performed using a fixed-effect model. Results: The electronic search yielde…

myalgiamedicine.medical_specialtyStatinmedicine.drug_classCochrane LibraryAsymptomaticGastroenterologylaw.inventionRandomized controlled triallawInternal medicinemedicineVitamin D and neurologyHumansVitamin Dbusiness.industryMyalgiaConfidence intervalSurgeryObservational Studies as TopicMeta-analysisHydroxymethylglutaryl-CoA Reductase Inhibitorsmedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersInternational Journal of Cardiology
researchProduct

Ortokeratoloģijas ietekme uz acs garuma un refrakcijas izmaiņām bērniem ar miopiju

2017

Darbs uzrakstīts angļu valodā uz 68 lapaspusēm, satur 17 attēlus, 10 tabulas un 73 literatūras atsauces. Darba mērķis bija salīdzināt acu aksiālā garuma un refrakcijas izmaiņas divām grupām tuvredzīgo jauniešu. Vienai grupai tuvredzība tika koriģēta ar ortokeratoloģiskajām kontaktlēcām (OK), bet otrajai ar brillēm. Pēc 18 mēnešiem tuvredzīgo pacientu grupai koriģētai ar brillēm acs aksiālais garums vidēji palielinājās par 0,20 mm, turpretī pacientiem koriģētiem ar OK kontaktlēcām tas bija tikai 0,05 mm. Pacientu grupai koriģētai ar OK kontaktlēcām tuvredzības pieaugums vidēji bija tikai -0,04 D, bet pacientiem koriģētiem ar brillēm tas bija -0,40 D. Refrakcijas izmaiņu atšķirība 0,36 D bija…

myopic progressionrefraction spherical equivalentorthokeratologymyopiaOptometrijaeye axial length
researchProduct

L'évolution de la représentation des médias de communication : le cas d'Internet

2008

the aim of this study is to show the evolution of the social representation of an object which gradually anchored in daily practices. Our approach is longitudinal the study took place during 5 years. 315 subjects were divided in 3 independent groups of regular users of Internet. Measurement was done at 3 times: in 2001, 2003 and 2005. Subjects are solicited for a verbal association task. Results are treated by a lexical analysis followed by a prototypic analysis (VERGES, 1992). Results show an important evolution of general organization of elements constituting the social representation. Discussion underlies two main points. First concerns modifications appearing inside the representation d…

méthodesInternetMédiasReprésentationCommunicationanalyse prototypique.[SHS.PSY]Humanities and Social Sciences/Psychologyprototypic analysisanalyse lexicaleScial representationsreprésentations socialesmethods[SHS.PSY] Humanities and Social Sciences/Psychology[ SHS.PSY ] Humanities and Social Sciences/Psychologylexical analysis
researchProduct

Purification of Nano-Porous Silicon for Biomedical Applications

2011

Recently, various bio-medical applications of nanoporous silicon (np-Si) have been suggested. This work investigates the biocompatibility of np-Si particles taking into account hazardous residua confined in the pores after preparation. The emphasis is on the potential application of such particles as oxygen photosensitizer for photodynamic therapy of cancer, which requires both negligible toxicity of np-Si particles in darkness and a high photo-cyto-toxic effect due to generation of singlet oxygen under illumination. Considerable amounts of water soluble toxic impurities are found to be present in the nanoporous shell of micrometer-sized np-Si particles immediately after their preparation b…

nano-porous silicon; biomedical applications; toxic impurities; purification; photodynamic therapyMaterials scienceBiocompatibilitySiliconSinglet oxygenNanoporouschemistry.chemical_elementNanotechnologyCondensed Matter PhysicsIsotropic etchingchemistry.chemical_compoundchemistryImpurityGeneral Materials SciencePhotosensitizerWafer
researchProduct